Cardiology & Internal Medicine & Nephrology & Family Medicine
MAPA (ambulatory blood pressure measurement)
Faire cet examen
Un professionnel peut évaluer si cet examen est indiqué pour vous et vous orienter, en clinique ou en téléconsultation.
Ambulatory blood pressure measurement (ABPM) - also known as blood pressure holter or 24-hour ambulatory BP recording - is the reference test for diagnosing and monitoring hypertension. It automatically measures blood pressure every 15-30 minutes over a 24-hour period (daytime) and every 30-60 minutes at night (night-time), providing a daytime average, a night-time average and an overall 24-hour average. ABPM is superior to office measurement for predicting cardiovascular events (risk of stroke + infarction + cardiovascular mortality) and for diagnosing certain specific hypertensive profiles: white coat hypertension (elevated BP only in the office but normal in the ambulatory - frequency 15-30 %) and masked hypertension (normal BP in the office but elevated in the ambulatory - underestimated, frequency 10-15 %, cardiovascular risk as high as sustained hypertension). According to Canadian guidelines (Hypertension Canada 2024) and INESSS Québec, ABPM is the preferred diagnostic tool for confirming the diagnosis of hypertension and adapting treatment. Home blood pressure measurement (HBPM) is a validated alternative to ABPM for diagnosis and follow-up, less costly and more accessible, but without nocturnal profile or data on blood pressure variability.
Technique, normal values and physiological phenomena
- MAPA technique and measurement conditions : equipment: validated oscillometric cuff + portable recorder → cuff placed on non-dominant arm (or dominant if significant difference between the two arms >10 mmHg - in this case use the arm with the highest BP) → cuff size adapted to arm circumference (cuff too small overestimates BP + too large underestimates it) → programming : measurements every 15-30 min during the day + every 30-60 min at night → minimum duration: 24h + valid recordings: at least 70 % of valid measurements + minimum 14 daytime measurements + minimum 7 nighttime measurements → instructions to the patient: normal activities of daily living + keep a diary (activities + medication intake + symptoms + bedtime and wake-up time) → keep arm still and relaxed during measurement → do not remove cuff → driving possible but immobilize arm + MAPA diagnostic values - hypertension thresholds: diurnal mean ≥135/85 mmHg = diurnal hypertension → nocturnal mean ≥120/70 mmHg = nocturnal hypertension → 24h mean ≥130/80 mmHg = 24h hypertension → recall office measurement: ≥140/90 mmHg = HTA + nocturnal dipping: blood pressure decreases physiologically at night by 10-20 % compared to the diurnal average → called dippers → non-dipper: nocturnal decrease 20 % → reverse dipper (riser): nocturnal BP > diurnal BP → important cardiovascular prognostic value: non-dipper and reverse dipper → increased cardiovascular and renal risk
- Physiological phenomena and specific blood pressure profiles : physiological phenomena measured by ABPM: BP variability: normal fluctuations in BP as a function of physical activity + emotions + stress + postural changes → morning surge: abrupt increase in BP on waking → associated with risk of morning stroke and infarction → alarm phenomenon (white coat effect) → white coat hypertension (WCH): BP ≥140/90 in the office + but normal ABPM (diurnal <135/85 + 24h <130/80) → prevalence: 15-30 % of hypertensives measured in the office → prognosis: fewer cardiovascular complications than sustained hypertension, but not benign → higher risk than normotension → annual monitoring recommended + Masked hypertension (MH): office BP <140/90 + but high ABPM (diurnal ≥135/85 or 24h ≥130/80) → prevalence: 10-15 % → underestimated and potentially dangerous → cardiovascular risk similar to sustained hypertension → Bobrie 2004 - JAMA + Hansen 2006 - Circulation → causes: isolated nocturnal hypertension + sleep apnea syndrome (SAS) + exercise-induced hypertension + occupational stress + diabetes + smoking + nephropathy → isolated nocturnal hypertension: nocturnal BP ≥120/70 + normal daytime BP → often associated with SAS + renal failure + heart failure + diabetes → treatment to be adapted (medication in the evening)
Indications, interpretation and therapeutic implications
| Appearance / indication | Data, interpretation and action | References and recommendations |
|---|---|---|
| MAPA indications and table of threshold values Indications Office-diagnosed hypertension - suspected white coat - masked hypertension - resistant hypertension - treatment assessment - nocturnal hypertension SAS - pregnancy - CKD - T1DM T2DM - labile hypertension - cardiovascular risk assessment - Hypertension Canada 2024 - MAPA vs MPAD |
Recommended indications for ABPM (Hypertension Canada 2024 + INESSS Québec): validated indications for ABPM: confirmation of the diagnosis of hypertension if in doubt (office BP 130-180/85-110 mmHg) → avoids over-diagnosis and under-diagnosisdiagnosis + suspicion of white coat hypertension (high BP in the office + anxious patient + normal BP at home) + suspicion of masked hypertension (borderline BP in the office + risk factors + target organ damage without confirmed hypertension in the office) + assessment of resistant resistant (poorly controlled BP despite ≥3 antihypertensive agents, including a diuretic) → exclude BBH + optimize treatment + assess therapeutic effect (24-hour blood pressure monitoring - validate nadir and peak action of medication) + nocturnal hypertension : sleep apnea syndrome (SAS) + CKD + diabetes + suspected nocturnal hypertension + pregnancy: screening for pre-eclampsia + blood pressure monitoring + labile hypertension + syncope + unexplained vertigo → summary table of diagnostic thresholds: Office BP: <130/85 = normal + 130-139/85-89 = high normal + ≥140/90 = HTA + Daytime (awake) ABPM: <130/80 = normal + ≥135/85 = HTA + Nocturnal (sleep) ABPM: <115/65 = normal + ≥120/70 = nocturnal HTA + 24h ABPM: <125/75 = normal + ≥130/80 = HTA + MPAD (home measurement): <130/80 = normal + ≥135/85 = HTA → agreement Hypertension Canada 2024 + ESH 2023 + ACC/AHA 2023 + ABPM vs MPAD: MAPA superior if: nocturnal profile required + nocturnal masked hypertension suspected + SAS + CKD + pregnancy + MPAD preferred if: long-term follow-up + accessibility + limited RAMQ reimbursement | Hypertension Canada 2024 guidelines : ABPM + indications + thresholds → current Canadian reference + Williams 2018 - JAMA : ABPM + CV risk prediction → superior cabinet measurement + Bobrie 2004 - JAMA : masked hypertension + ABPM + CV risk + Hansen 2006 - Circulation : masked hypertension + CV events + Dolan 2005 - Hypertension : ABPM + dipping + prognosis + ESH 2023 guidelines : ABPM + hypertension + European thresholds + ACC/AHA 2023 + INESSS Québec + RAMQ : ABPM → reimbursed according to medically justified indications. |
| Clinical interpretation and therapeutic implications sustained hypertension pharmacological treatment - white coat hypertension no immediate treatment - masked hypertension treat as sustained hypertension - nocturnal non-dipping evening treatment - excessive nocturnal dipping overdipping - morning hypertension - blood pressure targets - titration treatment - Hypertension Canada - ACTA chronotherapy |
ABPM interpretation and therapeutic implications: sustained hypertension (elevated ABPM + elevated office BP): pharmacological treatment indicated according to overall cardiovascular risk + comorbidities (CKD + T2DM + stroke + coronary artery disease) → blood pressure targets: <135/85 mmHg daytime ambulatory + or <130/80 mmHg over 24h → white coat hypertension (normal ABPM + elevated office BP): hygienic-dietary measures (HDM) → sodium reduction + physical activity + weight + alcohol → annual ABPM monitoring → pharmacological treatment deferred if no target organ damage (LVH + proteinuria + CKD) → but rigorous monitoring as BBH may evolve into sustained hypertension → masked hypertension (high ABPM + normal office BP): pharmacological treatment recommended even if office BP is normal → because cardiovascular risk is equivalent to sustained hypertension → Bobrie 2004 - JAMA + Hansen 2006 - Circulation + non-dipper profile (nocturnal fall <10 %): optimize antihypertensive treatment → shift medication intake to bedtime (chronotherapy) → treat underlying causes (SAS → CPAP + CKD + TD + heart failure) → ACCORD trial 2010 - NEJM: intensive blood pressure targets (<120/80 mmHg) in T2DM → no benefit on CV mortality vs standard (<140/90) → but SPRINT 2015 - NEJM: intensive target (20 %): risk of nocturnal ischemia (stroke + nocturnal infarction) if antihypertensive treatment too powerful → adapt nocturnal dosage → inverse dipper (nocturnal BP > diurnal BP): associated with risk of stroke + CKD + diabetes → look for and treat causes (SAS +++ + CKD + heart failure + diabetes)→ optimize chronotherapy + morning surge (morning increase): 24-hour antihypertensive coverage → check that the drug covers the morning period | Bobrie 2004 - JAMA: masked hypertension + ABPM + CV risk → reference + Hansen 2006 - Circulation: masked hypertension + CV + SPRINT 2015 - NEJM: intensive target <120 mmHg non-DT → reduction 25 % CV events + ACCORD 2010 - NEJM: intensive target T2D → no CV mortality benefit + Dolan 2005 - Hypertension: dipping + CV + renal prognosis → Williams 2018 - JAMA: ABPM + CV risk + Hypertension Canada 2024: masked hypertension + BBH + treatment → INESSS Québec + RAMQ: antihypertensive drugs → reimbursed according to indications |
| ABPM in special contexts - pregnancy, CKD, SAS MAPA grossesse prééclampsie - HTA nocturne IRC - MAPA DT1 DT2 - SAS apnées sommeil HTA nocturne - MAPA enfant adolescent - MAPA sujet âgé hypotension orthostatique - MAPA HTA résistante - MAPA blouse blanche âgé - faux positifs - labtartement brassard - remboursement RAMQ |
ABPM in special contexts: pregnancy - pre-eclampsia and gestational hypertension: ABPM very useful for distinguishing true gestational hypertension from white coat hypertension (frequent in pregnancy) + monitoring of nocturnal blood pressure profile (loss of nocturnal dipping = early sign of pre-eclampsia) → diagnostic thresholds in pregnancy: 24h ABPM ≥130/80 mmHg → target under treatment: 130-150/80-100 mmHg → methyldopa + labetalol + nifedipine retard (safe drugs in pregnancy) + chronic renal failure (CKD): frequent non-dipper profile + nocturnal hypertension → MAPA essential to optimize treatment + blood pressure target <130/80 mmHg (or 1 g/d) + ACEI or ARB (nephroprotection + proteinuria reduction) + iGLT2 (dapagliflozin + empagliflozin) if eGFR ≥20 → CKD progression reduction + sleep apnea syndrome (SAS) and nocturnal hypertension: SAS → activation of the sympathetic nervous system at night → nocturnal hypertension + non-dipper or inverse-dipper profile → Hypertension Canada: look for and treat SAS (CPAP - continuous positive airway pressure) + CPAP improves nocturnal blood pressure profile → Pepin 2009 - Hypertension: CPAP + SAS + nocturnal hypertension → nocturnal BP reduction + type 1 and type 2 diabetes : ABPM - screening for masked hypertension and nocturnal hypertension (frequent) + nocturnal hypertension associated with risk of albuminuria + diabetic CKD + retinopathy + ABPM in the elderly: frequent orthostatic hypotension (BP falling by ≥20/10 mmHg within 3 min of rising) → risk of falls + fractures → positional assessment + adapt treatment (reduce diuretics + alpha-blockers if severe orthostatic hypotension) | Hypertension Canada 2024 guidelines: ABPM + pregnancy + CKD + SAS → recommendations + Pepin 2009 - Hypertension: CPAP + SAS + nocturnal hypertension → BP reduction + Fagard 2009 - Journal of Hypertension: dipping + CKD + renal risk + Williams 2018 - JAMA: MAPA + superior + CV risk + ESH 2023 guidelines: MAPA + pregnancy + SAS + CKD + Cheung 2012 - Diabetologia: MAPA + DT + nocturnal hypertension → renal risk + INESSS Québec + RAMQ: MAPA → reimbursed + specific indications: CKD + pregnancy + SAS + resistant hypertension |
ℹ️
ABPM is the reference test for confirming the diagnosis of hypertension - superior to office measurement for predicting cardiovascular events: Diagnostic thresholds are 135/85 mmHg daytime and 130/80 mmHg over 24 hours. Masked hypertension (normal office BP but high ABPM) is as dangerous as sustained hypertension, and requires treatment. A non-dipper profile (no nocturnal drop in BP) is associated with increased cardiovascular and renal risk - look for sleep apnea syndrome or CKD.
Situations requiring urgent or priority care
ABPM reveals 24-hour mean BP ≥180/110 mmHg + or very high nocturnal BP (>170/100 mmHg) with no antihypertensive treatment in place → sustained severe hypertension → urgent initiation of antihypertensive treatment + work-up of repercussions (fundus + creatinine + proteinuria + ECG + LVH on echo) → if symptoms (headache + confusion + dyspnea + chest pain) → emergencies → hypertensive hypertension with target organ damage.
ABPM in pregnancy reveals nocturnal BP >135/85 mmHg + patient with proteinuria (>300 mg/d) + headache + or significant edema + or elevated transaminases → preeclampsia → obstetric emergency → HELLP workup (LDH + AST + platelets) + urgent obstetric consultation + antihypertensives suitable for pregnancy (labetalol + nifedipine) + magnesium sulfate if eclampsia.
ABPM reveals an inverse-dipper profile (nocturnal BP > diurnal BP) + or severe nocturnal hypertension in a patient complaining of snoring + apneas reported + excessive daytime sleepiness + morning fatigue → probable sleep apnea syndrome (SAS) → polysomnography + or screening test (ApneaLink + Nox T3) → CPAP if SAS confirmed → SAS treatment improves nocturnal blood pressure profile.
Consult at Clinique Omicron
Les médecins de Clinique Omicron prescrivent et interprètent la MAPA, distinguent l'HTA soutenue de l'HTA de la blouse blanche et de l'HTA masquée, détectent les profils non-dipper et inverse-dipper, initient ou adaptent le traitement antihypertenseur en conséquence (chronothérapie + cibles tensionnelles adaptées à l'IRC + à la grossesse + au diabète), dépistent le syndrome d'apnées du sommeil chez les patients avec profil nocturne pathologique, et assurent le suivi tensionnel à long terme par MAPA ou MPAD. Des consultations sont disponibles dans plusieurs points de service au Québec et en télémédecine. Pour prendre rendez-vous, choisissez votre service en ligne.
The contents of this page are provided for information purposes only and do not replace the advice of a physician or hypertension specialist. The interpretation of ABPM must always be made in the complete clinical context of the patient - the threshold values are guides, not absolute dogmas.
Omicron Clinic
Need to consult a doctor?
En clinique ou en télémédecine, partout au Québec.
Reçus pour assurances. Téléconsultation 7 j/7. Sans médecin de famille requis.